A Bengaluru startup is bringing diagnostics and medicines to the doorstep in minutes, and reshaping what people expect from healthcare at home.
We have grown used to speed everywhere else. Groceries in ten minutes, food at the door before the hunger sets in, a cab in three. Healthcare, oddly, stayed slow. Booking a blood test still means a half-day gone, an uncertain collection window, and a technician who may or may not show up on time. For something as personal as your health, the experience has stayed stubbornly inconvenient.
Zet Health, a Bengaluru startup, is trying to change that. Its bet is simple. If speed and reliability have become the default in every other part of daily life, home healthcare cannot stay an exception for much longer.
Operating in HSR Layout, one of Bengaluru’s densest neighbourhoods, Zet Health sends a trained phlebotomist to your door within ten minutes of booking a blood test. Medicines arrive just as fast. Every collection comes with complimentary vitals, a quick check of blood pressure, sugar, BMI and body temperature, at no extra cost. The idea is not just to run an errand for you, but to make a health touchpoint feel effortless.
The traction backs the thesis. In just over a year of operations, Zet Health has served more than 8,000 customers across upwards of 27,000 orders, and holds a 4.9 star rating on both the Play Store and the App Store, the kind of number that only shows up when the experience is consistently good. The company runs two models in parallel: a direct-to-consumer service for families, and a B2B2C model that puts its collection network to work for businesses and institutions.
What sets the approach apart is how it is built. Rather than chase the whole city at once, Zet Health runs a cluster-first model. It goes deep in one neighbourhood, builds enough phlebotomist density to hold that ten-minute promise, and only then moves to the next cluster. It is the same playbook that made quick commerce work, applied to a category where trust matters even more than speed.
“Healthcare has had its digital moment, but not its speed moment, at least not at home. People should be able to get a test done or medicine delivered without rearranging their day around it. We are building the rails for that, one cluster at a time, and doing it in a way we can actually keep reliable as we grow.”
says Ashutossh Daash, Co-founder and CEO of Zet Health.
There is a bigger vision underneath the ten-minute headline. The same infrastructure that brings a phlebotomist to your door can serve a family that wants a routine test, a company running health checks for its staff, or, in time, a patient recovering at home after a procedure. Change the customer, keep the engine. That is what lets a home-diagnostics business grow into something closer to a full home-healthcare platform, without rebuilding itself each time.
A large market, still waiting to be organised
The opportunity Zet Health is chasing is not a small one. India’s diagnostics market is estimated at over 15 billion dollars and is growing in low double digits each year, powered by rising chronic illness, greater health awareness, and a fast-growing appetite for preventive testing. Yet nearly 85 percent of it is still fragmented, run by thousands of standalone labs and collection agents with uneven quality and little technology. The organised and online segment, for all the attention it gets, is still a minority of the whole.
That is precisely the gap a speed-first, technology-led player can move into. The at-home segment in particular has grown sharply since the pandemic taught people they could get sampled without stepping out. Larger platforms such as Tata 1mg, Redcliffe Labs, Orange Health and Healthians have pushed home collection into the mainstream, while established chains like Dr Lal PathLabs, Metropolis and Thyrocare bring deep lab networks. Most of them, though, still treat home collection as a feature bolted onto an older operating model, rather than the core of how they run.
Zet Health’s wager is that speed and reliability, built in from the ground up with its own fleet and its own technology, is a category of its own. Owning the last mile rather than renting it, and going dense cluster by cluster rather than thin across a city, is what lets it hold a ten-minute promise that aggregator models struggle to match.
For now, the team is focused on proving the model cluster by cluster and earning the trust that lets it expand. If they are right about where healthcare is heading, the day is not far when waiting for a lab visit feels as outdated as waiting a week for a parcel.
